Product Overview
Epitalon is a tetrapeptide of alanine, glutamic acid, aspartic acid and glycine, written as AEDG and carrying a mass near 390 daltons. It is described in the literature as the active fragment of epithalamin, an older preparation made from pineal tissue, and Generic Peptides offers it as freeze-dried powder in 10 mg and 50 mg vials.
The claim that made this peptide famous is telomerase induction. In cultures of human cells, exposure to Epitalon for a number of days has been followed by measurable lengthening of telomeres, and a 2025 review describes the best response in culture at a concentration of about 10 ng/ml over 28 days. That is a laboratory observation. Inside a living body, the same effect has not been shown, and the gap between a culture dish and a person is the central problem with every promise attached to this vial.
Two other lines of work surround it. One concerns the pineal gland and melatonin, with reports of clock gene resynchronisation; the other is the general antioxidant and protective profile that Russian gerontology has attached to its peptide series. Neither has produced outcome data such as disease rates or mortality, and no large independent trial exists.
Dosage Protocol
There is no approved amount. Two very different figures circulate, and it is worth seeing both side by side: the public research convention and the much smaller quantities used in human studies.
| Lower published scheme | 5 mg daily for 10 days, the bottom of the convention most vendors print |
| Common convention | 5-10 mg per day across 10-20 days, repeated roughly yearly in the longevity context |
| Upper convention | 10 mg daily for up to 20 days; anything beyond that sits outside the published schemes |
| Human study reference | Clinical papers work nearer 0.5-1 mg daily, far below the vendor figure |
| Route | Subcutaneous or intramuscular injection |
| 10 mg plus 2 ml | Gives 5 mg/ml, where a 10 unit pull holds 500 mcg |
| 10 mg plus 5 ml | Gives 2 mg/ml and a 200 mcg pull at the same syringe mark |
| 50 mg plus 10 ml | Gives 5 mg/ml, matching the concentrated 10 mg vial |
| Vial yield | At 10 mg daily the 10 mg fill lasts a single day and the 50 mg fill lasts five |
| Female | No female-specific schedule appears in the sources checked |
The dilution routine is the familiar one: bacteriostatic water down the vial wall, a gentle roll, cold storage of both powder and solution, no freezing. Because the public figures are 5 to 10 times the quantities used in human research, a reader should understand where the gap came from before copying any number: the higher scheme appears to be a transfer from epithalamin extract work, and that transfer is the subject of published criticism.
Suggested Protocols
No experiment has combined Epitalon with another product from this catalogue, so the three groupings below are shelf maps rather than stacks. They separate the longevity items studied in the same Russian tradition, the redox and immune compounds compared with them, and the peptides that serve the sleep and cognition side of the same wish.
What to Expect
- Culture dish results. Telomere elongation is documented in human cell cultures after several days of exposure, and that is the strongest evidence in the whole file.
- Nothing equivalent in a body. An in vivo telomere effect has not been shown, which is the limitation the telomerase marketing usually omits.
- A separate circadian line. Reports of clock gene resynchronisation and interest in melatonin and pineal structure come from a different set of experiments, not from the telomerase work.
- Weeks, not days. In the research setting the response is judged across a course of weeks, so short experiments say nothing either way.
- No outcome endpoints. There are no large independent human studies and no data on disease or mortality, only intermediate markers and small trials.
- An unresolved dose question. The popular 5-10 mg figure is criticised as a transfer from extract research, which undermines any confident claim about what a course achieves.
Side Effects and Management
No monitored safety study supports the quantities sold here, and the published material on adverse events is thin. The rows below combine the injection-related events that apply to any peptide with the specific unanswered question around dose.
Post-Cycle Therapy
There is no hormonal aftermath here, so writing a recovery plan would mean inventing one. Epitalon is not an androgen, does not aromatise and does not reduce the production of testosterone, luteinising hormone or sperm.
One catalogue note for anyone reading the block as part of a wider plan: the immune peptide Thymalin is the item most often compared with it in the same Russian literature, and neither one has a laboratory marker that makes a course verifiable.
